Pharma Stocks Outlook for the week – 05 to 09.Oct.2015
( www.rupeedesk.in )
Pharmaceutical space is seen bullish and shares of Lupin Ltd and Dishman Pharmaceuticals
and Chemicals Ltd, in particular, will continue with their positive momentum
next week.
Shares
of Lupin gained steadily for the past six sessions and hit lifetime high
levels. The initial uptick in Lupin's stock was on account of Credit Suisse
upgrading its outlook on the drug maker after it increased the price of its
diabetes drug Fortamet by 200%.
Another
stock that outperformed its peers in the last few trading sessions, and is
expected to continue with its up run is Dishman Pharmaceuticals. The stock
today rose for the fourth consecutive session, ending up nearly 11% up. It
became one of the top gainers among CNX 500 constituents.
